DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 4Pfizer Inc
01 1CAPSULE
02 1CAPSULE;ORAL
03 1KAPSEL, MJUK
04 1Oral Solid Dosage Form
05 1Tafamidis 20Mg 30 Joined' Oral Use
01 1Lead Market Dossiers- Under Development
02 1Prescription
03 1RX
04 2Blank
01 2VYNDAQEL
02 2Vyndaqel
03 1Blank
01 1Canada
02 1India
03 1Sweden
04 1U.S.A
05 1USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : VYNDAQEL
Dosage Form : CAPSULE;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2019-05-03
Application Number : 211996
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Vyndaqel
Dosage Form : KAPSEL, MJUK
Dosage Strength : 20 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : U.S.A
Brand Name : Vyndaqel
Dosage Form : Tafamidis 20Mg 30 Joined' Oral Use
Dosage Strength : 30 cps 20 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : VYNDAQEL
Dosage Form : CAPSULE
Dosage Strength : 20MG
Packaging : 120
Approval Date :
Application Number : 2495732
Regulatory Info : Prescription
Registration Country : Canada
